Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
36.5 GBX
Market Closed
Updated:
May 22, 2024
Creo Medical Group PLC
EPS (Diluted)
|
Creo Medical Group PLC
EPS (Diluted) Peer Comparison
Comparables:
SN
LIVN
LMDX
EKF
AGL
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Creo Medical Group PLC
LSE:CREO
|
EPS (Diluted)
£0
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
EPS (Diluted)
$0
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
EPS (Diluted)
$0
|
CAGR 3-Years
59%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
EPS (Diluted)
£0
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Angle PLC
LSE:AGL
|
EPS (Diluted)
£0
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's EPS (Diluted)?
EPS (Diluted)
-0.1
GBP
-0.1
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's EPS (Diluted) amounts to -0.1 GBP.
What is Creo Medical Group PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-3%
-3%
Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for Creo Medical Group PLC have been -3% over the past three years .
You don't have any saved screeners yet
